There are processes in place within Health Canada for a thorough review before a drug is approved for market. Pre-market surveillance is completed. At the same time, once that process is done and a drug is approved, we have a system in place, which we introduced, that addresses that through the Drug Safety and Effectiveness Network. Some of those adverse reactions can only be reported after the fact. There is a system in place to allow patients, as well as doctors, to provide that information to Health Canada so that we can follow up and investigate. There are two processes—
On November 20th, 2012. See this statement in context.